- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical use of CCR5 inhibitors in HIV and beyond ; volume:9 ; number:1 ; day:27 ; month:1 ; year:2011 ; pages:1-14 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (27.1.2011), 1-14, 12.2011
- Creator
-
Gilliam, Bruce L.
- Contributor
-
Riedel, David J.
Redfield, Robert R.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-S1-S9
- URN
-
urn:nbn:de:1111-2016041439006
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gilliam, Bruce L.
- Riedel, David J.
- Redfield, Robert R.
- SpringerLink (Online service)
Other Objects (12)
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
The chemokine receptor CCR5: multi-faceted hook for HIV-1
Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
The chemokine receptor CCR5: multi-faceted hook for HIV-1
Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
The chemokine receptor CCR5: multi-faceted hook for HIV-1
Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1